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SUMMARY 
Inflammation is a prevalent and debilitating disease that affects the human beings 
vigorously. The study was intended to evaluate the anti-inflammatory activity of whole 
plant of Celosia polygonoids (EECP). EECP constituting phytoconstituents to treat adjuvant 
induced inflammation rats to minimize the side effects. The anti-inflammatory activity 
study was carried out by using adjuvant induced model, cotton pellet, croton oil, 
formaldehyde, histamine and serotonin induced oedema of Wistar albino strain rats. 
EECP was injected at different doses such as 100 and 300 mg/kg/i.p., and the study was 
compared with standard drug Indomethacin (10 g/kg).  The results obtained from the 
above methods were subjected to statistical analysis. The study was conducted paw 
volume for an each interval time and days carried out. The plant has various 
phytoconstituents such as reducing sugars, flavonoids saponins, starch, and steroids. 
Significantly one among those phytoconstituents lessens to oedema of the rodents.  The 
EECP showed the maximum inhibitory activity at (300 mg/kg/i.p.) by dose dependent 
manner. These inhibitions were statistically significant (p<0.01). From these results 
indicate that EECP is a bioactive agent and having significant results in anti-inflammatory 
and action by inhibition of the exudation, and leukocytes recruitment into the inflamed 
tissues and bone regeneration calcium deposition. 
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1. Introduction 
Herbal medicines are being used by about 
80% of the world population primarily in the 
developing countries for primary health care. 
They have stood through the test of time for their 
safety, efficacy, cultural acceptability and lesser 
side effects. Ancient literature also mentions 
herbal medicines for various diseases, for which 
no scientific proof is available. In the present 
study of the inflammation may be acute, sub-
acute and chronic inflammation. Inflammatory 
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response occurs in three distinct phases. The first 
phase is caused by an increased in vascular 
permeability resulting in exudation of fluids 
from the blood into the interstitial space, the 
second phase involves the infiltrations of 
leukocytes from the blood into the tissue and in 
third phase granuloma formation and tissue 
repair. Mediators of inflammation originate 
either from plasma (e.g. complement proteins. 
Kinins) or from cells (e.g. histamine, 
Prostaglandins, Cytokines). The production of 
active mediators is triggered by microbial 
products or by host proteins, such as proteins of 
the complement, kinins and coagulation systems 
that are themselves are activated by microbes 
and damaged tissues. Generally the mediators of 
inflammation are Histamine, Prostaglandins 
(PGs), Leukotrienes (LTB4), Nitric oxide (NO), 
Platelet-activation factor (PAF), Bradykinin, 
Serotonin, Lipoxins, Cytokines, Growth Factors. 
Large amount of experimental studies and 
detailed knowledge that arises of mediators of 
inflammation has been carried out. This paper 
address the commonly used animal model for 
the evaluation of anti-inflammatory activity in 
laboratory practice. It is also giving the principle 
and procedure behind using each animal model. 
This paper hopefully fills the expectation to 
provide the in vivo models in area of 
inflammation [1]. 
2. Materials and Methods 
Plant Collection  
The leaves of Celosia polygonoids which 
predominantly is a habitat in arid places were 
procured from Alampatti Pudhur, Manaparai 
district, Tamil Nadu during the month of 
December-January.  
Authentication  
The freshly collected plant was then 
authenticated by the botanist from Botanical 
Survey of India, Coimbatore, Tamil Nadu, India 
and a voucher specimen of the plant were 
submitted in our laboratory (Voucher No. 
BSI/SC/5/23/06-07/Tech.1260). 
Garbling process  
Garbling refers to the separation of that 
portion of the plant to be used from other parts 
of the plant, dirt and other extraneous matter. 
This step is often done during the collection 
process. Although there are machines that 
perform garbling, usually garbling is performed 
by hand. After removing all such unwanted 
adhered materials; the collected materials were 
then spread over trays and dried under shade, 
with regular sifting of collected plant materials 
everyday to avoid growth of fungus. Such shade 
dried bark/leaves/aerial portions of plant were 
ground in grinder to powder and then subjected 
for extraction [2]. 
Soxhlet extraction  
The powdered bark of known quantity was 
taken in a soxhlet apparatus and extracted with 
absolute ethanol. The material was extracted 
continuously for 72 hours. The crude ethanol 
extract was then concentrated by distilling off the 
solvent under reduced pressure/vacuum and 
subjected for further studies [2].  
Phytochemical screening 
The methods of [3,4,5,6] were used to screen 
the chemical constituents the EECP. The 
presence of alkaloid (Dragendroff reagent and 
Mayer’s reagent), flavonoids (Shinoda test), 
steroids (Liberman Burchard test) and terpenes 
(Vanillin–sulfuric acid reagent) were assessed.  
In vivo study of Anti-inflammatory activity 
in EECP 
Carrageenan induced oedema  
Twenty four rats were equally divided into 
four groups assigned Latin numbers I–IV. 
Animals were fasted, with free access to water, 
16 h before the experiment. Groups I was served 
as positive control group by inducing the 0.1 ml 
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of carrageenan dissolved in isotonic saline to the 
right hind paw, animals in group II were 
intraperitoneally treated with indomethacin as 
standard anti-inflammatory drug (10 mg/kg). 
While groups III and IV was received EECP in 
two doses; (100 and 300 mg/kg), respectively. 
Dosing volume was kept constant and was 
completed with saline when required. The choice 
of the used doses and time of measurement and 
sampling was based on pilot studies in our 
laboratory. Thirty minutes after oral treatment, 
group I received 0.05 ml saline, while groups II–
IV received 0.05 ml carrageenan (1% solution in 
saline) on the plantar surface of the right hind 
paw. The right hind paw volume was measured 
immediately after carrageenan injection by water 
displacement using modified digital 
plethysmometer (Tokyo, Japan) [7]. The volume 
was measured again sequentially 1, 2, 3, 4 and 
24th h after carrageenan injection and 
immediately. The results were expressed as 
percentage inhibition in relation to the control 
group. Then the paw volume was tabulated and 
found the average volumes and the percentage 
inhibition was calculated by mean paw volume. 
Cotton pellet induced granuloma 
Twenty four rats were taken equally divided 
into four groups assigned as I-IV. All groups 
were implanted the cotton pellet by the 
following procedure. Cotton pellets were 
weighing about 10±1 mg were autoclaved up to 
20 minutes. Cotton pellets were aseptically 
implanted in the interscapular distance under 
the skin on the previously shaved back of the 
rats which were anesthetized with 25 mg/kg 
sodium pentobarbital intraperitoneally [8]. 
Inflammation induced animals were 
acclimatized. Animals belonging to the group I 
served as positive control with implanted cotton 
pellet without any treatment. Group II served as 
standard drug i.e., Indomethacin (10 mg/kg) 
and group III and IV served as EECP (100 and 
300 mg/kg) respectively and treated the groups 
up to 7 days by intraperitoneally. After 7 days 
the animals were sacrificed and the pellets 
together with the granuloma tissues were 
carefully removed, dried in an oven at 60 0C. The 
pellets were weighed both moist and dry. Mean 
weight of the granuloma tissue was recorded. 
The weight of the pellets taken out from drug 
administered rats was compared with the weight 
of the pellets taken out from the control group 
and indomethacin administered rats was 
reported by earlier workers [9, 10, 11]. The 
percentage inhibition also calculated by the 
mean value of the cotton pellet granuloma.  
Croton Oil Induced Ear Oedema  
The experiment was performed using a 
slight modification of the procedure described by 
[12].  An irritant solution was prepared by 
dissolving 4 parts croton oil (the irritant) in a 
solvent mixture of 10 parts ethanol, 20 parts 
pyridine, and 66 parts ethyl ether. Croton oil 
irritant solution prepared was applied (0.1 ml) to 
the inner surface of the right ear of rats. Twenty 
four rats were equally arranged in four groups 
numbered I–IV. Irritant solution was injected to 
right ear disc of the all groups. Group I served 
and hence received only the irritant solvent 
mixture and known as positive control group i.e., 
induced croton oil in the right ear disc without 
any treatment and the left ear was kept untreated. 
Group II was served as standard drug i.e., 
indomethacin (10 mg/kg) by intraperitoneally. 
Group III and IV were served as EECP in two 
different concentrations employed; such 100 and 
300mg/kg respectively [13]. One hour later, 
groups II–IV received croton oil solution after the 
administration of drug. After 4 h, animals were 
decapitated. An 8-mm cork borer was used to 
punch out discs from both the treated as well as 
the control ears. The punches were weighed 
immediately after decapitation and the 
difference in weight was used to assess the 
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inflammatory response. Results were expressed 
as milligram of tissue i.e., ear disc. Each ear disc 
was weighed and compared with control. Mean 
weight of the ear granuloma tissue was recorded. 
The weight of the ear granuloma taken out from 
drug administered rats was compared with the 
weight of the ear granuloma taken out from the 
control group and indomethacin i.e., standard 
drug was administered to rats reported by [14]. 
The percentage inhibition was calculated by the 
mean value of the ear discs weight taken from 
the study. 
Formaldehyde Induced Oedema  
The experiment was slightly varied from the 
carrageenan induced oedema method. Animals 
were used twenty four equally divided into four 
groups. The formaldehyde (2% v/v) solution, 
0.02 ml, was injected in the first and third day 
into the left hind paw just beneath the plantar 
aponeurosis to induce inflammation. Group I 
served as the positive control as given the 
formaldehyde solution prepared by following 
method. Group II served as the standard drug 
administration with positive control. Group III 
and IV served as the EECP (100 and 300 
mg/kg/i.p.). The standard drug (10 mg/kg/i.p.) 
and EECP at the dose of 100 & 300 mg/kg/i.p. 
administered, once a day, for 7 days. The paw 
volume was measured by using modified digital 
plethysmometer for 7 days continuously. The 
drug administered paw volume results were 
compared with standard and control group [15]. 
The percentage inhibition was calculated by the 
mean value of the paw volume taken from the 
study. The results were expressed as percentage 
inhibition in relation to the control group. Then 
the paw volume was tabulated and found the 
average volumes and the percentage inhibition 
was calculated by mean paw volume. 
Histamine and Serotonin Induced Oedema 
The procedure same as that like carrageenan-
induced paw edema, only instead of carrageenan 
the rats are challenged by a subcutaneous 
injection of 0.1ml of 1% solution of histamine and 
serotonin individually into the sub-plantar side 
of the right hind paw. The paw volume was 
measured after the treatment and before the 
treatment. The animals were taken in a four 
groups and group I was served as positive 
control and given 0.1 ml of histamine and 
serotonin individually into right hind paw. 
Group II was served as standard drug i.e., 
indomethacin (10 mg/kg/i.p.). Group III and IV 
was served as EECP (100 and 300 mg/kg/i.p.) 
respectively. The drug administered paw 
volume results were compared with standard 
and control group. The percent inhibition of the 
inflammation is calculated using the formula and 
compared with control group.  
Percentage inhibition  
Percentage inhibition =   Vci - Vt   x 100 
                              Vc 
Vc - Positive Control group Average Paw 
Volume  
Vt - Drug Treated group Average Paw 
Volume 
Statistical analysis 
The experimental results were expressed as 
the mean±SD. Data were statistically evaluated 
by one way ANOVA followed by Duncan’s 
multiple range post hoc test. 
Table. 1. Phytochemical Analysis of EECP  
S.NO Chemical Constituents  EECP 
1. Alkaloids + 
2. Amino Acids  - 
3. Anthraquinones - 
4. Flavonoids + 
5. Glycosides + 
6. Proteins - 
7. Reducing sugars + 
8. Saponins - 
9. Starch + 
10. Steroids + 
11. Tannins - 
12. Terpenoids - 
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Table. 2. Anti-inflammatory activity of EECP - Carrageenan induced method-Paw volume (in ml) and 
Percentage inhibition (in %) 
Groups  1st Hour  2nd Hour  3rd Hour  4th Hour  24th Hour 
Positive Control 1.53±0.06 1.66±0.05 1.77±0.03 1.82±0.02 1.93±0.03 
Indomethacin (10 
mg/kg) 
1.06±0.11a 
(30.944) 
0.94±0.06a 
(43.01) 
0.87±0.04b 
(50.66) 
0.78±0.05b,c 
(56.81) 
0.49±0.01a 
(74.19) 
EECP 
(100mg/kg) 
1.20±0.04c,d  
 (21.82) 
1.17±0.05e,f 
(29.51) 
1.12±0.05d  
(36.44) 
1.07±0.08c   
(41.46) 
 1.02±0.07c 
(47.30) 
EECP 
(300mg/kg) 
1.27±0.03d,e 
(17.26) 
1.22±0.03d  
(26.50) 
1.12±0.04c 
(36.72) 
0.98±0.05g 
(43.36) 
0.79±0.03d,e 
(51.81) 
F 17.939 41.736 58.541 89.307 199.602 
df 6, 35 6, 35 6, 35 6, 35 6, 35 
P Value <0.001 <0.001 <0.001 <0.001 <0.001 
Values are mean±SD. (N=6), c,d,e,fP<0.05, bP<0.01, aP<0.001, with respect to control. Ns, P>0.05 (Anova 
followed by new DMRT). 
 
Table. 3. Anti-inflammatory activity of EECP- treatment in Cotton pellet , Croton oil, Histamine & Serotonin 
induced oedema method 
Groups Cotton pellet                 
weight (in mg) 
Ear Disc weight             
(in mg/kg) 
Paw Volume          
(in ml) 
Paw Volume         
(in ml) 
Positive Control  39.66±1.84 16.15±1.26 1.52±0.08 1.31+0.04 
Indomethacin              (10 
mg/kg) 
19.79±2.01a 
(50.10) 
5.53±0.89a 
(65.75) 
0.38±0.02a 
(75.00) 
0.34+0.02a 
(74.04) 
EECP (100 mg/kg) 33.61±1.48c 
(15.25) 
15.69±1.48c 
(2.84) 
0.69±0.03b,c 
(54.6) 
0.62+0.04b 
(52.67) 
EECP (300 mg/kg) 31.53±1.22b 
(20.49) 
12.97±1.45b 
(19.69) 
0.67±0.02b 
(55.92) 
0.56+0.03a 
(57.25) 
F 71.551 43.681 278.708 244.481 
df   6, 35 6, 35 6, 35 6, 35 
P Value < 0.001 < 0.001 <0.001 <0.001 
Values are mean±SD. (N=6), c,dP<0.05, bP<0.01, aP<0.001, with respect to control. Ns, P>0.05 (Anova 
followed by new DMRT).
 
Table. 4. Anti-inflammatory activity of EECP- treatment in Formaldehyde induced oedema method 
Groups 1st Day 2nd Day 3rd Day 4th Day 5th Day 6th Day 7th Day 
Positive control 1.21±0.03 1.23±0.02 1.26±0.01 1.30±0.02 1.35±0.01 1.38±0.01 1.42±0.02 
Indomethacin  
(10 mg/kg) 
1.09±0.02 0.89±0.02b 
(27.64) 
0.73±0.03a 
(42.06) 
0.58±0.01a 
(55.38) 
0.50±0.01
b (62.96) 
0.38±0.007
a 
(72.46) 
0.38±0.01a 
(72.46) 
EECP   
(100 mg/kg) 
1.20±0.01 
(0.82) 
1.06±0.03e 
(13.82) 
0.97±0.01 
(23.01) 
0.84±0.01
d (35.38) 
0.70±0.01   
(48.14) 
0.63±0.02   
(54.34) 
0.60±0.00d 
(57.74) 
EECP  
(300 mg/kg) 
1.18±0.01 
(2.47) 
1.04±0.02e  
(15.44) 
0.94±0.01d 
(25.39) 
0.82±0.02c
,d (36.92) 
0.66±0.03
f (51.11) 
0.58±0.008
g (57.97) 
0.57±0.01c 
(59.85) 
F - 44.873 100.759 174.216 224.378 503.103 512.422 
df - 6, 35 6, 35 6, 35 6, 35 6, 35 6, 35 
P Value - <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
Values are mean±SD. (N=6), c,dP<0.05, bP<0.01, aP<0.001, with respect to control. Ns, P>0.05 (Anova 
followed by new DMRT). 
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3. Results and Discussion 
Inflammatory diseases affect a significant 
portion of the population worldwide and have 
been intensely studied for several decades. 
Inflammation is protective and defense 
mechanism of the body. During inflammatory 
conditions various pathological changes are take 
place.  
The EECP showed that anti-inflammatory 
activity at the dose of 100 and 300 mg/kg/i.p., 
when compared with positive control and 
standard drug indoemthacin (10 mg/kg/i.p.). In 
carrageenan induced method EECP showed 
(47.30%, 51.81%) inhibition at 24th hour, 
carrageenan early is an exudative phase of 
inflammatory pathology was reported by [16] 
that involved the action of vasoactive amines, 
such as histamine, serotonin, and kinins on 
vascular permeability [17, 18, 19].  
 
Figure. 1. Comparative Evaluation of Anti-
inflammatory study on EECP 
 
 
 
 
 
 
 
 
 
 
 
Subcutaneous injection of carrageenan into 
the rat paw produces plasma extravasations and 
inflammation characterized by increased tissue 
water and plasma protein exudation with 
neutrophils extravasations and metabolism of 
arachidonic acid by both cyclooxygenase and 
lipoxygenase enzyme pathways [20]. It was 
observed by the increased paw volume under 
the digital plethysmometer in experimental rats 
in this study [21] suggested that the early 
hyperemia of carrageenan-induced oedema 
results from the release of histamine and 
serotonin. Thus Carrageenan-induced paw 
oedema in rats appears to be a biphasic events 
and the early phase (2.5–3 h) of the inflammation 
is due to the release of vasoactive amines such as 
histamine and serotonin. In the later phase (4.5–6 
h) is due to the activation of kinin-like substances 
such as prostaglandins, proteases and lysosome 
[22]. The first phase showed that the EECP 
reduced the inflammation by control the 
proliferation of the histamine and serotonin and 
in second phase controlled the stimulation of 
kinin like substances. [23] Was reported that 
leukocyte adhesion represents one of the first 
steps in the inflammatory response initiation and 
it is essential for accumulation of active immune 
cells at sites of inflammation.  
The extracts reduced the paw volume in 
which first phase the EECP showed the (36.44% 
& 36.72%) inhibition as that the histamine and 
serotonin like substances reduced. In the second 
phase the EECP showed that the (47.30% & 
51.81%) inhibition, those results showed that the 
reduced kinin like substances level. In cotton 
pellet induced method (15.25%, 20.49%) 
inhibition on 7th day observation. From the 
above study we can be concluded that the EECP 
shows the anti-inflammatory activity and the 
inhibitory effect is dose dependent. In croton oil 
induced method (2.84 % & 19.69%) inhibition 
after 7 hours, at the doses of 100 & 300 
mg/kg/i.p., respectively.  
In the third method ear oedema the most 
important mediators are involved as 
prostaglandins, histamine and serotonin, 
whereas the lypoxygenase pathway has no 
important role [24]. The method has certain 
advantages for natural product testing [25]. But 
190 
0
10
20
30
40
50
60
70
80
C
ar
ra
ge
en
an
 
C
ot
to
n 
C
ro
to
n 
oi
l
H
is
ta
m
in
es
Se
ro
to
ni
n
Fo
rm
al
de
hy
de
Positive control
Indomethacin (10 mg/kg)
EECP (100 mg/kg)
EECP (300 mg/kg)
P. Rajesh et. al. /J Phytol 1 (2009) 185-192 
 
peripherally acting drugs such as aspirin, 
indomethacin and dexamethasone only inhibit 
the later phase [26]. So, the herbal treatment is 
very suitable to this ear oedema method. Also 
the EECP showed that the anti-inflammatory 
activity by reduced ear disc weight. In the 
formaldehyde induced method the EECP 
showed that paw volume on 7th day (57.74% & 
59.85%) inhibition, which showed that the extract 
reduced the inflammation as much as so.  
In the histamine and serotonin method, this 
reduced the paw volume (54.6% & 55.92%) and 
(52.67% & 57.25%) inhibition at 100 & 300 
mg/kg/i.p., respectively. Statistical analysis 
showed that the oedema inhibitions of 
preparations containing extract is significantly 
different from the control group at all the 
concentrations tested and the activity is dose-
dependent i.e., 300 mg/kg/i.p.,. These methods 
revealed that the elevated percentage inhibition 
of EECP. Although direct evidence of the 
mechanism of action of extract is not clear. 
Flavonoids exhibit anti-inflammatory activity 
was reported [27]. Those flavonoids having 
deliberately reduced the mediators on inflamed 
area.  
According to this, flavonoids presented in 
leaves extract activate the immune cells to 
control the inflamed area. Those results showed 
that the carrageenan induced inflammation 
showed that reduced inflammation when 
compared to other inflammatory models. From 
these results indicated that EECP is a bioactive 
agent and having significant results in anti-
inflammatory activity by inhibition of the 
exudation, and leukocytes recruitment into the 
inflamed tissues.  
From the evaluation the EECP has confirmed 
that having the pharmacological action against 
the inflammatory condition and it can be used 
further molecular compound analysis to 
enumerate the chemical to action.  
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